GURUFOCUS.COM » STOCK LIST » Technology » Software » Neurones (XPAR:NRO) » Definitions » Capex-to-Operating-Cash-Flow

Neurones (XPAR:NRO) Capex-to-Operating-Cash-Flow : 0.26 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Neurones Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Neurones's Capital Expenditure for the six months ended in Dec. 2023 was €-12.02 Mil. Its Cash Flow from Operations for the six months ended in Dec. 2023 was €46.88 Mil.

Hence, Neurones's Capex-to-Operating-Cash-Flow for the six months ended in Dec. 2023 was 0.26.


Neurones Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Neurones's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurones Capex-to-Operating-Cash-Flow Chart

Neurones Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.11 0.10 0.19 0.25

Neurones Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 1.09 0.12 0.24 0.26

Competitive Comparison of Neurones's Capex-to-Operating-Cash-Flow

For the Information Technology Services subindustry, Neurones's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurones's Capex-to-Operating-Cash-Flow Distribution in the Software Industry

For the Software industry and Technology sector, Neurones's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Neurones's Capex-to-Operating-Cash-Flow falls into.



Neurones Capex-to-Operating-Cash-Flow Calculation

Neurones's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-17.982) / 72.075
=0.25

Neurones's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-12.016) / 46.883
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurones  (XPAR:NRO) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Neurones Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Neurones's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurones (XPAR:NRO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Software » Neurones (XPAR:NRO) » Definitions » Capex-to-Operating-Cash-Flow
Traded in Other Exchanges
Address
Immeuble Le Clemenceau 1 - 205, Avenue Georges Clemenceau, Nanterre Cedex, Paris, FRA, 92024
Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second most profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.